About ENVISAGENICS INC
Envisagenics is a biotechnology company leveraging AI and RNA biology to discover novel therapeutic targets for oncology and neurodegenerative diseases. The company was founded in 2014 and has developed an AI platform called SpliceCore®.
AI-driven analysis of RNA splicing for drug target discoveryDevelopment of novel, prevalent, and disease-specific drug targetsResearch collaborations in immuno-oncology and RNA-targeted treatments for neurodegenerative diseases
Is this your company?
Claim ENVISAGENICS INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim ENVISAGENICS INC & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.